![Duncan Young](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Duncan Young
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Duncan Young via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Sofinnova Partners SAS
![]() Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Private Equity Investor Private Equity Investor | |
OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Equipment/Instruments | Director/Board Member | |
Ares Life Sciences LP
![]() Ares Life Sciences LP Investment ManagersFinance Ares Life Sciences LP provides financing for small and medium sized companies. It focuses on key life sciences sectors, mainly: pharmaceuticals and biotechnology, medical diagnostics, and medical technology. | Investment Managers | Chief Investment Officer | |
Novo Holdings Ltd.
![]() Novo Holdings Ltd. Financial ConglomeratesFinance Part of Iron Mountain, Inc., Novo Holdings Ltd. functions as an investment holding British company. The company is based in London, UK. | Financial Conglomerates | Chief Investment Officer | |
University College London | College/University | Doctorate Degree | |
Synthace Ltd.
![]() Synthace Ltd. Packaged SoftwareTechnology Services Synthace Ltd. produces bio-based chemical and biological products through synthetic biology. It is a synthetic biology company with a platform of technologies for the rapid engineering and optimization of novel biological production systems. The bioengineering platform is broadly applicable across multiple industry sectors, including the production of specialty chemicals from renewable feed stocks using efficient and sustainable processes. The company was founded by Sean Ward and Markus Christian Gershater in January 2011 and is headquartered in, London, the United Kingdom. | Packaged Software | Director/Board Member | |
University of Birmingham | College/University | Graduate Degree | |
Association of Engineering Doctorates | Corporate Officer/Principal | ||
Abingworth LLP
![]() Abingworth LLP Investment ManagersFinance Abingworth LLP (Abingworth) is a venture capital firm founded in the year 1973 Peter Dickson and Anthony Montagu. The firm headquartered in London and additional offices in San Francisco and Boston. Abingworth LLP became part of The Carlyle Group Inc. (NASDAQ: CG) on 3rd August 2022. | Investment Managers | Private Equity Investor | |
Peel Hunt LLP
![]() Peel Hunt LLP Investment Banks/BrokersFinance Peel Hunt LLP is an independent securities brokerage firm headquartered in London, UK. The firm was founded in 1989 as a market liquidity provider to retail and institutional investors. They provide bespoke dealing and execution services for institutional asset managers, registrars, private client wealth managers and private banks. | Investment Banks/Brokers | Analyst-Equity | |
Leweston School | Director/Board Member | ||
Evox Therapeutics Ltd.
![]() Evox Therapeutics Ltd. BiotechnologyHealth Technology Evox Therapeutics Ltd. develops and markets transformational therapeutics. The firm creates novel exosome-based biotherapeutics for the treatment of various severe diseases with limited options for patients and their families. The company was founded by Matthew Wood, Per Lundin, and Samir EL Andaloussi in 2016 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member | |
University of Aberdeen | College/University | Undergraduate Degree | |
Imperial College London | College/University | Graduate Degree | |
Lone Pine Capital (UK) Ltd.
![]() Lone Pine Capital (UK) Ltd. Investment ManagersFinance Lone Pine Capital UK Ltd. (Lone Pine-UK) is the Great Britain-based alternative investment subsidiary of Lone Pine Capital LLC in the US. Headquartered in London, Lone Pine-UK was founded in 2002 and provides investment management services to pooled investment vehicles as well as pension and profit-sharing plans. | Investment Managers | Chief Executive Officer | |
Larkham Ltd. | Director/Board Member | ||
Sgw Research Ltd. | Director/Board Member | ||
Hy. Duke & Son Ltd.
![]() Hy. Duke & Son Ltd. Specialty StoresRetail Trade Hy. The private company is based in Dorchester, UK, and their fine art salerooms are centrally located in the county town, close to the main Dorchester South railway station. Duke & Son Ltd. is a British company that deals with militaria and sporting goods, as well as silver and objects of vertu. The company also provides valuations for inheritance tax assessment. The company was founded in 1999, and Lee Young has been the CEO of the company since 2017. | Specialty Stores | Corporate Officer/Principal | |
Piper Sandler Ltd.
![]() Piper Sandler Ltd. Investment Banks/BrokersFinance Part of Piper Sandler Cos., Piper Sandler Ltd. is a brokerage services provider. The company is based in London, UK. The British company was founded in 1999. Neil Robert Mackison has been the CEO of the company since 2006. | Investment Banks/Brokers | Analyst-Equity | |
Novo Principal Investments
![]() Novo Principal Investments Investment ManagersFinance Novo Principal Investments (Novo Principal) is a private equity operating division of Novo Nordisk Fonden. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Analyst | |
Abingworth Bioequities Master Fund Ltd. | Investment Trusts/Mutual Funds | Director/Board Member | |
EPIGENOMICS AG | Medical Specialties | Director/Board Member | |
The Wellcome Trust Ltd.
![]() The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
First Sentier Investors (UK) IM Ltd.
![]() First Sentier Investors (UK) IM Ltd. Investment ManagersFinance First Sentier Investors (UK) IM Ltd. (FSIIM) is the wholly-owned, Great Britain-based specialist asset management subsidiary of S.I. Holdings Ltd., ultimately held by Mitsubishi UFJ Financial Group, Inc. (TYO: 8306) in Japan. Headquartered in Edinburgh, the firm was founded in 1970 and formerly known as First State Investment Management (UK) Ltd. FSIIM provides discretionary investment management and portfolio management services to a range of institutional clients and funds. | Investment Managers | Corporate Officer/Principal | |
Abingworth Management Ltd.
![]() Abingworth Management Ltd. Investment ManagersFinance Abingworth Management Ltd. operates as an investment firm with interests in the life sciences and healthcare sectors. It offers services for businesses in all stages of company development, including early and late-stage venture financing, growth equity, and public companies. The company was founded in 1973 and is headquartered in London, the United Kingdom. | Investment Managers | Corporate Officer/Principal | |
Autolus Ltd.
![]() Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | Biotechnology | Director/Board Member | |
AMARIN CORPORATION PLC | Pharmaceuticals: Major | Director/Board Member | |
Arix Bioscience /Venture Capital/
![]() Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience /Venture Capital/ (Arix Bioscience) is a venture capital subsidiary of Arix Bioscience Plc founded in 2015 by Christopher Thomas Evans, Jonathan M. Peacock and Joseph Anderson. The firm is headquartered in London, United Kingdom with an additional offices in New York. | Investment Managers | Chief Executive Officer | |
AUTOLUS THERAPEUTICS PLC | Biotechnology | Director/Board Member | |
COMMONWEALTH BANK OF AUSTRALIA | Major Banks | Corporate Officer/Principal | |
University of Aston | College/University | Doctorate Degree | |
Queen Mary's College | College/University | Undergraduate Degree | |
Cytos Ltd. | Director/Board Member | ||
Novartis Foundation | Corporate Officer/Principal | ||
The Bridport Literary Festival Ltd. | Director/Board Member |
Statistieken
Internationaal
Verenigd Koninkrijk | 28 |
Zwitserland | 3 |
Frankrijk | 2 |
Verenigde Staten | 2 |
Denemarken | 2 |
Sectoraal
Finance | 13 |
Consumer Services | 7 |
Health Technology | 7 |
Miscellaneous | 3 |
Electronic Technology | 2 |
Operationeel
Director/Board Member | 20 |
Corporate Officer/Principal | 8 |
Private Equity Investor | 4 |
Independent Dir/Board Member | 4 |
Chief Investment Officer | 3 |
Sterkste connecties
Insiders | |
---|---|
Joseph Anderson | 19 |
Tom Burt | 11 |
Sarah Gordon-Wild | 11 |
- Beurs
- Insiders
- Duncan Young
- Bedrijfsconnecties